| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |